Issue Stories

Von Willebrand’s Disease Marker

For the quantitation of vWF activity in human plasma

 The REAADS von Willebrand factor activity ELISA uses a purified monoclonal antibody that recognizes the portion of the vWF molecule that binds platelet glycoprotein Ib. This is the same portion of vWF that is activated by ristocetin in the Ristocetin Cofactor Assay. Ristocetin Cofactor methods are technically demanding and have considerable inter- and intravariability. Also available is a full panel of ELISA format tests for the assessment of vWD, which includes the REAADS vWF activity test, the Corgenix Collagen binding assay (for investigational use only), and the REAADS vWF antigen test.

Corgenix Inc
(800) 729-5661; www.corgenixonline.com

|
|

MEDIA CENTER

Interactive Media
Resources
Classifieds
Calendar
Consumer Resources
Media Kit
Advertiser Index
EAB
Reprints

ADDITIONAL ONLINE RESOURCES

Allied Healthcare
Medical Education
24X7mag
Chiropractic Products Magazine
Clinical Lab Products (CLP)
Orthodontic Products
The Hearing Industry Resource
HME Today
Rehab Management
Physical Therapy Products
Plastic Surgery Products
Imaging Economics
Medical Imaging
RT Magazine
Sleep Review
SynerMed Communications
IMED Communications
Practice Growth
Practice Builders
powered by:
Copyright © 2008 Ascend Media LLC | Clinical Lab Products | All Rights Reserved.
Privacy Policy | Terms of Service